Navigation Links
Groundbreaking discovery of mechanism that controls obesity, atherosclerosis
Date:7/5/2012

A*STAR scientists from the Institute of Molecular and Cell Biology (IMCB) and the Singapore Bioimaging Consortium (SBIC) have discovered a new signalling pathway that controls both obesity and atherosclerosis. The team demonstrated, for the first time, that mice deficient in the Wip1 gene were resistant to weight gain and atherosclerosis via regulation of the Ataxia telangiectasia mutated gene (ATM) and its downstream signalling molecule mTor. These groundbreaking findings were published in the journal Cell Metabolism on 3rd July and may provide significant new avenues for therapeutic interventions for obesity and atherosclerosis.

Obesity and atherosclerosis-related diseases account for over one-third of deaths in the Western world. Controlling these conditions remains a major challenge due to an incomplete understanding of the molecular pathways involved. Atherosclerosis, a progressive disease of the large arteries, is an underlying cause of many cardiovascular diseases. In Singapore, 10.8% of our population is obese and cardiovascular disease accounted for 31.9% of all deaths in 2010.

Obesity and atherosclerosis are accompanied by the accumulation of lipid droplets in adipocytes (fat cells) and in foam cells respectively. Foam cells can subsequently rupture, damaging blood vessels, and contributing to further progression of atherosclerosis. The scientists discovered that Wip1 deficient mice, even when fed a high-fat diet, were resistant to obesity and atherosclerosis by preventing the accumulation of lipid droplets. This appeared to be through increased autophagy, the normal process by which the body degrades its own cellular components. They showed that the Wip1 deficient mice exhibited increased activity of ATM which decreased mTor signalling, resulting in increased autophagy. This degraded the lipid droplets and suppressed obesity and atherosclerosis.

"This is the first time that Wip1-dependent regulation of ATM-mTor pathway has been linked to authophagy and cholesterol efflux thus providing an entirely new avenue for treatment of obesity and atherosclerosis," said Dr Dmitry Bulavin, Senior Principal Investigator at IMCB and lead author of this paper.

Mapping the mechanism to cancer

The scientists are hopeful that this ATM-mTor pathway could similarly map onto cancer to suppress tumour progression. Similar to suppression of obesity and atherosclerosis, activation of autophagy in cancer cells could result in degradation of cellular content that is essential for cancer cells to sustain rapid proliferation. This, in turn, will result in suppression of cancer growth.

Said Dr Dmitry Bulavin, "We are building on this research to investigate if the same mechanism could also control tumour progression and hence potentially unlock new therapeutic treatments targeting Wip1, ATM and mTor in cancer as well and the preliminary results are promising."

This discovery also adds to the growing significance of ATM as an important gene with a key role in protecting us from major pathological conditions. Previous work has established Wip1-dependent regulation of ATM as a potent regulator of tumorigenesis via activation of tumour-suppressor p53. Together, these three pathological conditions - obesity, atherosclerosis and cancer - account for more than 70% of mortality worldwide, making ATM-related pathways very attractive therapeutic targets.

8Prof Hong Wanjin, Executive Director of IMCB, said, "This is the first time that these important molecules have been integrated into a linear pathway that plays a prominent role in controlling obesity and atherosclerosis. It is a fine example of how fundamental research can shed light on biological and medical questions to potentially open new avenues of formulating therapeutic strategies for the benefit of patients."


'/>"/>

Contact: Ong Siok Ming
ong_siok_ming@a-star.edu.sg
65-682-66254
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Related biology news :

1. Groundbreaking discovery of the cellular origin of cervical cancer
2. Lawson recieves Grand Challenges Explorations grant for groundbreaking research
3. Discovery may lead to new tomato varieties with vintage flavor and quality
4. 7 pharmaceutical companies join academic researchers to speed TB drug discovery
5. Discovery increases understanding how bacteria spread: U of A study
6. NSF Leadership in Discovery and Innovation sparks White House US Ignite Initiative
7. Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
8. New discovery provides insight on long-standing pregnancy mystery
9. Speeding up drug discovery with rapid 3-D mapping of proteins
10. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
11. A whale of a discovery: New sensory organ found in rorqual whales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
Breaking Biology Technology: